# Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

> **NCT02708186** · PHASE2 · COMPLETED · sponsor: **Axovant Sciences Ltd.** · enrollment: 34 (actual)

## Conditions studied

- Dementia With Lewy Bodies
- REM Sleep Behavior Disorder
- Parkinson's Disease Dementia

## Interventions

- **DRUG:** Nelotanserin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02708186
- **Lead sponsor:** Axovant Sciences Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02708186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02708186, "Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02708186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*